FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: biopharmaceutical company

Sort
E.g., 2013-06-20
E.g., 2013-06-20
Enter a comma separated list of user names.

GILD, Gilead Sciences Incorporated

Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN) previously reported the initiation of Phase I clinical studies, in collaboration with the National Cancer Institute (NCI), for two of the Company’s novel oncology product candidates, EZN-2968 and EZN-2208 (PEG-SN38). Both EZN-2968 and EZN-2208 have been shown to down-modulate HIF-1, a subunit of HIF-1.

Pages

ADVERTISE WITH US